Digital Look

Welcome to Digital Look++,
you are not logged in

Amgen Inc. (AMGN)

$ 270.91

Amgen Receives CHMP Positive Opinion for Prolia(...	18-Dec-2009	PR Newswire
Data Presented at San Antonio Breast Cancer Symp...	10-Dec-2009	PR Newswire
Amgen Presents Data From First Nplate(R) Study i...	07-Dec-2009	PR Newswire
Nplate(R) Data From MDS Studies Presented at ASH	06-Dec-2009	PR Newswire
Amgen Highlights Data to be Presented at ASH	30-Nov-2009	PR Newswire
Amgen Provides Update on Status of Prolia(TM) (D...	19-Oct-2009	PR Newswire
Sunlight Research(TM), Releases Its Amgen EPO Pa...	14-Sep-2009	PR Newswire
Data Show Medication Adherence is an Important F...	13-Sep-2009	PR Newswire
Amgen Issues Statement on Outcomes of Advisory C...	13-Aug-2009	PR Newswire
Amgen to Discuss Denosumab Data at Today's Advis...	13-Aug-2009	PR Newswire
Studies Published in the New England Journal of ...	11-Aug-2009	PR Newswire
Amgen to Collaborate With GlaxoSmithKline to Com...	27-Jul-2009	PR Newswire
Amgen Announces KRAS Safety Update to U.S. Presc...	17-Jul-2009	PR Newswire
Amgen to Participate in Reproductive Health Drug...	22-Jun-2009	PR Newswire
New Study Shows Nplate(R) Significantly Reduces ...	07-Jun-2009	PR Newswire
VIDEO from Medialink and Amgen: New Survey Highl...	27-May-2009	PR Newswire
FDA Accepts Amgen's Submission and Files Biologi...	18-Feb-2009	PR Newswire
Independent Data Monitoring Committee Recommends...	11-Feb-2009	PR Newswire
Nplate(R) Approved in the European Union for the...	06-Feb-2009	PR Newswire
Amgen Submits Biologics License Application for ...	19-Dec-2008	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.